[Answered] The product of the nuclear reaction in which 28Si is subjected to neutron capture followed by alpha ...

This topic contains a solution. Click here to go to the answer

Author Question: The product of the nuclear reaction in which 28Si is subjected to neutron capture followed by alpha ... (Read 21 times)

Chloeellawright

Hero Member
Posts: 588

on: Aug 27, 2018

The product of the nuclear reaction in which 28Si is subjected to neutron capture followed by alpha emission is ________.

A) 31S
B) 33S
C) 23Mg
D) 25Mg
E) 25Al

Question 2

Solve the following equation: 2 x 3 x 4 x 5

A. 120
B. 120
C. 1
D. 2

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

Liddy

Sr. Member
Posts: 342

Reply #1 on: Aug 27, 2018

Answer to Question 1

D

Answer to Question 2

A

Chloeellawright

Member
Posts: 588

Reply 2 on: Aug 27, 2018

Gracias!

AmberC1996

Member
Posts: 317

Reply 3 on: Yesterday

Great answer, keep it coming

« previous next »

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.